Cargando…

Inhibition of Wdr5 Attenuates Ang-II-Induced Fibroblast-to-Myofibroblast Transition in Cardiac Fibrosis by Regulating Mdm2/P53/P21 Pathway

Cardiac fibrosis is an important pathological process in many diseases. Wdr5 catalyzes the trimethylation of lysine K4 on histone H3. The effects of Wdr5 on the cardiac fibrosis phenotype and the activation or transformation of cardiac fibroblasts were investigated by Ang-II-infused mice by osmotic...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Jiali, Peng, Hong, Mo, Binfeng, Yin, Chengye, Fang, Guojian, Li, Yingze, Wang, Yuepeng, Chen, Renhua, Wang, Qunshan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687631/
https://www.ncbi.nlm.nih.gov/pubmed/36358925
http://dx.doi.org/10.3390/biom12111574
_version_ 1784836054998581248
author Yuan, Jiali
Peng, Hong
Mo, Binfeng
Yin, Chengye
Fang, Guojian
Li, Yingze
Wang, Yuepeng
Chen, Renhua
Wang, Qunshan
author_facet Yuan, Jiali
Peng, Hong
Mo, Binfeng
Yin, Chengye
Fang, Guojian
Li, Yingze
Wang, Yuepeng
Chen, Renhua
Wang, Qunshan
author_sort Yuan, Jiali
collection PubMed
description Cardiac fibrosis is an important pathological process in many diseases. Wdr5 catalyzes the trimethylation of lysine K4 on histone H3. The effects of Wdr5 on the cardiac fibrosis phenotype and the activation or transformation of cardiac fibroblasts were investigated by Ang-II-infused mice by osmotic mini-pump and isolated primary neonatal rat cardiac fibroblasts. We found that the Wdr5 expression and histone H3K4me3 modification were significantly increased in Ang-II-infused mice. By stimulating primary neonatal rat cardiac fibroblasts with Ang II, we detected that the expression of Wdr5 and H3K4me3 modification were also significantly increased. Two Wdr5-specific inhibitors, and the lentivirus that transfected Sh-Wdr5, were used to treat primary mouse cardiac fibroblasts, which not only inhibited the histone methylation by Wdr5 but also significantly reduced the activation and migration ability of Ang-II-treated fibroblasts. To explore its mechanism, we found that the inhibition of Wdr5 increased the expression of P53, P21. Cut&Tag-qPCR showed that the inhibition of Wdr5 significantly reduced the enrichment of H3K4me3 in the Mdm2 promoter region. For in vivo experiments, we finally proved that the Wdr5 inhibitor OICR9429 significantly reduced Ang-II-induced cardiac fibrosis and increased the expression of P21 in cardiac fibroblasts. Inhibition of Wdr5 may mediate cardiac fibroblast cycle arrest through the Mdm2/P53/P21 pathway and alleviate cardiac fibrosis.
format Online
Article
Text
id pubmed-9687631
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96876312022-11-25 Inhibition of Wdr5 Attenuates Ang-II-Induced Fibroblast-to-Myofibroblast Transition in Cardiac Fibrosis by Regulating Mdm2/P53/P21 Pathway Yuan, Jiali Peng, Hong Mo, Binfeng Yin, Chengye Fang, Guojian Li, Yingze Wang, Yuepeng Chen, Renhua Wang, Qunshan Biomolecules Article Cardiac fibrosis is an important pathological process in many diseases. Wdr5 catalyzes the trimethylation of lysine K4 on histone H3. The effects of Wdr5 on the cardiac fibrosis phenotype and the activation or transformation of cardiac fibroblasts were investigated by Ang-II-infused mice by osmotic mini-pump and isolated primary neonatal rat cardiac fibroblasts. We found that the Wdr5 expression and histone H3K4me3 modification were significantly increased in Ang-II-infused mice. By stimulating primary neonatal rat cardiac fibroblasts with Ang II, we detected that the expression of Wdr5 and H3K4me3 modification were also significantly increased. Two Wdr5-specific inhibitors, and the lentivirus that transfected Sh-Wdr5, were used to treat primary mouse cardiac fibroblasts, which not only inhibited the histone methylation by Wdr5 but also significantly reduced the activation and migration ability of Ang-II-treated fibroblasts. To explore its mechanism, we found that the inhibition of Wdr5 increased the expression of P53, P21. Cut&Tag-qPCR showed that the inhibition of Wdr5 significantly reduced the enrichment of H3K4me3 in the Mdm2 promoter region. For in vivo experiments, we finally proved that the Wdr5 inhibitor OICR9429 significantly reduced Ang-II-induced cardiac fibrosis and increased the expression of P21 in cardiac fibroblasts. Inhibition of Wdr5 may mediate cardiac fibroblast cycle arrest through the Mdm2/P53/P21 pathway and alleviate cardiac fibrosis. MDPI 2022-10-27 /pmc/articles/PMC9687631/ /pubmed/36358925 http://dx.doi.org/10.3390/biom12111574 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Yuan, Jiali
Peng, Hong
Mo, Binfeng
Yin, Chengye
Fang, Guojian
Li, Yingze
Wang, Yuepeng
Chen, Renhua
Wang, Qunshan
Inhibition of Wdr5 Attenuates Ang-II-Induced Fibroblast-to-Myofibroblast Transition in Cardiac Fibrosis by Regulating Mdm2/P53/P21 Pathway
title Inhibition of Wdr5 Attenuates Ang-II-Induced Fibroblast-to-Myofibroblast Transition in Cardiac Fibrosis by Regulating Mdm2/P53/P21 Pathway
title_full Inhibition of Wdr5 Attenuates Ang-II-Induced Fibroblast-to-Myofibroblast Transition in Cardiac Fibrosis by Regulating Mdm2/P53/P21 Pathway
title_fullStr Inhibition of Wdr5 Attenuates Ang-II-Induced Fibroblast-to-Myofibroblast Transition in Cardiac Fibrosis by Regulating Mdm2/P53/P21 Pathway
title_full_unstemmed Inhibition of Wdr5 Attenuates Ang-II-Induced Fibroblast-to-Myofibroblast Transition in Cardiac Fibrosis by Regulating Mdm2/P53/P21 Pathway
title_short Inhibition of Wdr5 Attenuates Ang-II-Induced Fibroblast-to-Myofibroblast Transition in Cardiac Fibrosis by Regulating Mdm2/P53/P21 Pathway
title_sort inhibition of wdr5 attenuates ang-ii-induced fibroblast-to-myofibroblast transition in cardiac fibrosis by regulating mdm2/p53/p21 pathway
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687631/
https://www.ncbi.nlm.nih.gov/pubmed/36358925
http://dx.doi.org/10.3390/biom12111574
work_keys_str_mv AT yuanjiali inhibitionofwdr5attenuatesangiiinducedfibroblasttomyofibroblasttransitionincardiacfibrosisbyregulatingmdm2p53p21pathway
AT penghong inhibitionofwdr5attenuatesangiiinducedfibroblasttomyofibroblasttransitionincardiacfibrosisbyregulatingmdm2p53p21pathway
AT mobinfeng inhibitionofwdr5attenuatesangiiinducedfibroblasttomyofibroblasttransitionincardiacfibrosisbyregulatingmdm2p53p21pathway
AT yinchengye inhibitionofwdr5attenuatesangiiinducedfibroblasttomyofibroblasttransitionincardiacfibrosisbyregulatingmdm2p53p21pathway
AT fangguojian inhibitionofwdr5attenuatesangiiinducedfibroblasttomyofibroblasttransitionincardiacfibrosisbyregulatingmdm2p53p21pathway
AT liyingze inhibitionofwdr5attenuatesangiiinducedfibroblasttomyofibroblasttransitionincardiacfibrosisbyregulatingmdm2p53p21pathway
AT wangyuepeng inhibitionofwdr5attenuatesangiiinducedfibroblasttomyofibroblasttransitionincardiacfibrosisbyregulatingmdm2p53p21pathway
AT chenrenhua inhibitionofwdr5attenuatesangiiinducedfibroblasttomyofibroblasttransitionincardiacfibrosisbyregulatingmdm2p53p21pathway
AT wangqunshan inhibitionofwdr5attenuatesangiiinducedfibroblasttomyofibroblasttransitionincardiacfibrosisbyregulatingmdm2p53p21pathway